tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ABVX Stock Latest News

Citizens JMP healthcare analysts hold an analyst/industry conference call
The FlyCitizens JMP healthcare analysts hold an analyst/industry conference call
10d ago
ABVX
PTGX
Abivax’s Obefazimod: A Promising Contender in Ulcerative Colitis Treatment with Potential Market Impact
PremiumRatings
Abivax’s Obefazimod: A Promising Contender in Ulcerative Colitis Treatment with Potential Market Impact
13d ago
ABVX
Positive Outlook for Abivax SA: Anticipated Success of Obefazimod in Ulcerative Colitis Treatment
PremiumRatings
Positive Outlook for Abivax SA: Anticipated Success of Obefazimod in Ulcerative Colitis Treatment
16d ago
ABVX
Buy Rating Justified for Abivax SA: Promising Efficacy of Obefazimod in Ulcerative Colitis and Crohn’s Disease
PremiumRatings
Buy Rating Justified for Abivax SA: Promising Efficacy of Obefazimod in Ulcerative Colitis and Crohn’s Disease
25d ago
ABVX
Abivax’s Potential in IBD Market: Buy Rating Backed by Phase 3 Trials and Industry Trends
PremiumRatings
Abivax’s Potential in IBD Market: Buy Rating Backed by Phase 3 Trials and Industry Trends
1M ago
ABVX
Abivax SA Shareholders Approve 2024 Financials and Board Appointments
PremiumCompany AnnouncementsAbivax SA Shareholders Approve 2024 Financials and Board Appointments
1M ago
6K
ABVX
Promising Outlook for Abivax’s Obefazimod in Ulcerative Colitis with Upcoming Phase 3 Results as Key Catalyst
Premium
Ratings
Promising Outlook for Abivax’s Obefazimod in Ulcerative Colitis with Upcoming Phase 3 Results as Key Catalyst
2M ago
ABVX
Abivax SA Reports Increased Losses Amid R&D Expansion
Premium
Company Announcements
Abivax SA Reports Increased Losses Amid R&D Expansion
2M ago
ABVX
Abivax Reports First Quarter 2025 Financial Results with Increased R&D Costs
PremiumCompany Announcements
Abivax Reports First Quarter 2025 Financial Results with Increased R&D Costs
2M ago
6K
ABVX
ABVX Earnings this Week: How Will it Perform?
PremiumPre-Earnings
ABVX Earnings this Week: How Will it Perform?
2M ago
ABVX
Optimistic Buy Rating for Abivax SA: Obefazimod’s Potential in Ulcerative Colitis and Market Opportunity
PremiumRatings
Optimistic Buy Rating for Abivax SA: Obefazimod’s Potential in Ulcerative Colitis and Market Opportunity
2M ago
ABVX
Promising Potential of Abivax SA’s Obefazimod in Ulcerative Colitis Drives Buy Rating
PremiumRatings
Promising Potential of Abivax SA’s Obefazimod in Ulcerative Colitis Drives Buy Rating
3M ago
ABVX
Optimistic Buy Rating for Abivax SA Driven by Promising Phase 3 Developments and Market Potential
PremiumRatingsOptimistic Buy Rating for Abivax SA Driven by Promising Phase 3 Developments and Market Potential
3M ago
ABVX
Abivax completes enrollment in ABTECT trials
Premium
The Fly
Abivax completes enrollment in ABTECT trials
3M ago
ABVX
Abivax Completes Enrollment for Phase 3 Ulcerative Colitis Trials
Premium
Company Announcements
Abivax Completes Enrollment for Phase 3 Ulcerative Colitis Trials
3M ago
6K
ABVX
Abivax management to meet with BTIG
PremiumThe Fly
Abivax management to meet with BTIG
3M ago
ABVX
Abivax Announces AGM Details and Board Appointment Amid 2025 Milestones
PremiumCompany Announcements
Abivax Announces AGM Details and Board Appointment Amid 2025 Milestones
3M ago
6K
ABVX
Abivax Reports 2024 Financial Results, Eyes Clinical Milestones
PremiumCompany Announcements
Abivax Reports 2024 Financial Results, Eyes Clinical Milestones
3M ago
ABVX
Abivax SA: Promising Clinical Developments and Positive Outlook Justify Buy Rating
PremiumRatings
Abivax SA: Promising Clinical Developments and Positive Outlook Justify Buy Rating
4M ago
ABVX
Promising Prospects for Abivax: Buy Rating Backed by Clinical Progress and Financial Strength
PremiumRatingsPromising Prospects for Abivax: Buy Rating Backed by Clinical Progress and Financial Strength
4M ago
ABVX
Abivax SA’s Obefazimod: A Promising Blockbuster in Ulcerative Colitis Treatment
Premium
Ratings
Abivax SA’s Obefazimod: A Promising Blockbuster in Ulcerative Colitis Treatment
4M ago
ABVX
Positive Outlook for Abivax: Buy Rating Supported by Promising Phase 3 Trials and Strong Financial Position
Premium
Ratings
Positive Outlook for Abivax: Buy Rating Supported by Promising Phase 3 Trials and Strong Financial Position
4M ago
ABVX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >